Amsterdam Gastroenterology Endocrinology Metabolism
-
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study
Evren, I., Brouns, E. R., Wils, L. J., Poell, J. B., Peeters, C. F. W., Brakenhoff, R. H., Bloemena, E. & de Visscher, J. G. A. M., 1 Nov 2020, In: Oral Oncology. 110, 10 p., 105014.Research output: Contribution to journal › Article › Academic › peer-review
-
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
Wils, L. J., Poell, J. B., Evren, I., Koopman, M. S., de Visscher, J. G. A. M., Brakenhoff, R. H. & Bloemena, E., 1 Jun 2020, In: Modern Pathology. 33, 6, p. 1033-1040 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia
Wils, L. J., Poell, J. B., Peferoen, L. A. N., Evren, I., Brouns, E. R., de Visscher, J. G. A. M., van der Meij, E. H., Brakenhoff, R. H. & Bloemena, E., Nov 2023, In: Journal of Oral Pathology and Medicine. 52, 10, p. 930-938 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy
Bakema, J. E., van Walsum, M. S., Harris, J. R., Ganzevles, S. H., Muthuswamy, A., Houtkamp, M., Plantinga, T. S., Bloemena, E., Brakenhoff, R. H., Breij, E. C. W. & van de Ven, R., 12 Oct 2023, (E-pub ahead of print) In: Molecular Cancer Therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
-
Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia
Evren, I., Wils, L. J., Poell, J. B., Brakenhoff, R. H., Bloemena, E. & de Visscher, J. G. A. M., Oct 2023, In: Oral diseases. 29, 7, p. 2667-2676 10 p.Research output: Contribution to journal › Article › Academic › peer-review